Oppenheimer Asset Management Inc. Zai Lab LTD Transaction History
Oppenheimer Asset Management Inc.
- $7.78 Billion
- Q1 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 16,689 shares of ZLAB stock, worth $564,088. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,689Holding current value
$564,088% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
150Shares Held
48.5MCall Options Held
103KPut Options Held
439K-
Janus Henderson Group PLC London, X06.57MShares$222 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$217 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$107 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$84.8 Million1.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.35MShares$79.6 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.31B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...